Clinical Trial

Growth And Safety Outcomes In Infants With Cow´s Milk Protein Allergy (CMPA) Fed A Novel Extensively Hydrolyzed Formula (eHF)

Name: Growth And Safety Outcomes In Infants With Cow´s Milk Protein Allergy (CMPA) Fed A Novel Extensively Hydrolyzed Formula (eHF) — clinical trial record (NCT07711938)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

Growth and safety Outcomes in infants with CMPA fed a novel extensively hydrolyzed formula.

Trial Details

NCT Number	NCT07711938
Lead Sponsor	Société des Produits Nestlé (SPN)
Conditions	Cow Milk Protein Allergy
Enrollment	410 participants
Start Date	2026-07-01
Primary Completion	2028-07-31 (estimated)
Study Completion	2029-05-30 (estimated)
Updated on ClinicalTrials.gov	2026-07-17